
Trends in Antiviral Drug Development
6 contributors - Hardback
£135.00
Find out more
Michael J. Sofia, Ph.D. is Co-founder and Chief Scientific Officer of Arbutus Biopharma, Inc. where he established the programs in HBV-cure and coronavirus therapeutics.
Zhengqiang Wang, Ph.D. is Professor and Director of Chemistry at the Center for Drug Design, College of Pharmacy, University of Minnesota.